ArticleOncoimmunology2016

Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs.

E C Halvorsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.